Sargramostim therapy (Innoventus Project)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSargramostim therapy (Innoventus Project)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsPeriodontitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInnoventus Project Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoventus Project Ab
Active IndicationsN/A
Inactive IndicationsPeriodontitis

Other Information

ATC CodeN/A
Related LinksDrugBank